Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2017-04-25Clinical Trial Update: cGA in Newly-diagnosed Elderly MM Patients: a Multi-center, Prospective, Non-interventional Study.
A multicenter, prospective, non-interventional study assessing Comprehensive Geriatric Assessment in newly diagnosed elderly patients with m…
-
CLINICAL_TRIALS research · 2017-04-24Clinical Trial Update: S0340 MRI and Fludeoxyglucose F18 PET in Diagnosing Solitary Plasmacytoma [Phase 2]
Phase 2 clinical trial S0340 evaluating MRI and FDG PET for diagnosing solitary plasmacytoma was terminated, per SWOG Cancer Research Networ…
-
CLINICAL_TRIALS research · 2017-03-27Clinical Trial Update: Collection of Additional Data Followed the Study IFM 2013-04
This document notes a clinical trial update focused on collecting additional data after the IFM 2013-04 study in multiple myeloma.
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation [NA]
Pilot study evaluating whether hyperbaric oxygen therapy can improve outcomes during autologous peripheral blood stem cell transplantation i…
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Phase I Study of CS-7017 and Bexarotene [Phase 1]
Phase I trial of CS-7017 in combination with Bexarotene for solid tumors, lymphoma, and multiple myeloma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-02-09Clinical Trial Update: Comparing Intermediate-dose CTX+ G-CSF Plus or Not rhTPO for PB CD34+ Cells Mobilization in MM Patients [NA]
A clinical trial comparing intermediate-dose cyclophosphamide plus G-CSF with or without recombinant human thrombopoietin for mobilizing per…
-
CLINICAL_TRIALS research · 2017-01-12Clinical Trial Update: Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide)
An observational registry of Chinese patients with multiple myeloma treated with lenalidomide (Revlimid) has been terminated.
-
CLINICAL_TRIALS research · 2016-10-07Clinical Trial Update: S0120, Studying Blood and Bone Marrow Samples From Patients With Monoclonal Gammopathy of Undetermined Significance, Multiple Myeloma, or Plasmacytoma
This clinical trial update describes the S0120 study that collects blood and bone marrow samples from patients with monoclonal gammopathy of…
-
CLINICAL_TRIALS research · 2016-10-04Clinical Trial Update: Prevalence of Ocular Disorders in Multiple Myeloma (MM-OO-16)
This completed clinical trial (MM-OO-16) investigates the prevalence of ocular disorders in patients with multiple myeloma.
-
CLINICAL_TRIALS research · 2016-08-24Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry on a Cohort of Patients Receiving Plerixafor
This study analyzes data from the EBMT registry on patients receiving plerixafor, summarizing outcomes in lymphoma and multiple myeloma.
-
CLINICAL_TRIALS research · 2016-08-17Clinical Trial Update: Institut Paoli Calmettes Multiple Myeloma Database
This document is a clinical trial update for the Institut Paoli-Calmettes Multiple Myeloma Database, which is currently recruiting participa…
-
CLINICAL_TRIALS research · 2016-07-26Clinical Trial Update: Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization [NA]
This entry reports a pharmacokinetic and pharmacodynamic study of lenograstim for hematopoietic stem cell mobilization in multiple myeloma, …
-
CLINICAL_TRIALS research · 2016-07-20Clinical Trial Update: Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL) in Latin America
This is a completed observational study conducted in Latin America evaluating participants with chronic lymphocytic leukemia, multiple myelo…
-
CLINICAL_TRIALS research · 2016-06-24Clinical Trial Update: Autologous Stem Cell Transplantation for Myeloma Patients Over 65 Years
Clinical trial update on autologous stem cell transplantation for newly diagnosed multiple myeloma patients over 65; current status of the t…
-
CLINICAL_TRIALS research · 2016-06-20Clinical Trial Update: A Study to Record in an Observational Manner the Treatment of Multiple Myeloma as it is Being Done in Every Day Practice Without Providing Any Investigational Drug or Prescribing Any Procedure
This is an observational registry study documenting real-world treatment of multiple myeloma without any investigational drugs; the study st…
-
CLINICAL_TRIALS research · 2016-06-14Clinical Trial Update: Bortezomib as First Salvage Therapy for Myeloma Patients Previously Exposed to Bortezomib as Initial Treatment.
A clinical trial update examining bortezomib as a first salvage therapy for multiple myeloma patients who were previously exposed to bortezo…
-
CLINICAL_TRIALS research · 2016-06-06Clinical Trial Update: Identification of Hematological Malignancies and Therapy Predication Using microRNAs as a Diagnostic Tool
Clinical trial update describes research on using microRNAs as a diagnostic tool to identify hematological malignancies and predict therapeu…
-
CLINICAL_TRIALS research · 2016-06-03Clinical Trial Update: Adherence to Lenalidomide Treatment in Multiple Myeloma - Prevalence, Characteristics and Clinical Significance
This clinical trial update examines adherence to lenalidomide therapy in multiple myeloma, including prevalence, characteristics of non-adhe…
-
CLINICAL_TRIALS research · 2016-06-02Clinical Trial Update: Open-label Study of TH-302 and Dexamethasone With or Without Bortezomib or Pomalidomide in Subjects With Relapsed/Refractory Multiple Myeloma [Phase 1, Phase 2]
This document describes an open-label Phase 1/2 trial evaluating TH-302 (evofosfamide) with dexamethasone, with or without bortezomib or pom…
-
CLINICAL_TRIALS research · 2016-05-17Clinical Trial Update: Total Skeletal Irradiation in Multiple Myeloma Before Second Autologous Hematopoietic Stem Cell Transplantation [Phase 1]
Phase 1 trial evaluating total skeletal irradiation before a second autologous hematopoietic stem cell transplantation in multiple myeloma. …
-
CLINICAL_TRIALS research · 2016-05-10Clinical Trial Update: Single Autologous Stem Cell Transplantation Followed by Maintenance Therapy as Front-line Treatment for Myeloma [Phase 3]
Phase 3 trial evaluating single autologous stem cell transplantation followed by maintenance therapy as front-line treatment for multiple my…
-
CLINICAL_TRIALS research · 2016-05-04Clinical Trial Update: A Study Conducted in Subjects With Relapsed/Refractory Multiple Myeloma (MM); to Determine Dose of Afuresertib in Combination With Carfilzomib (Part 1) and to Investigate the Safety, Pharmacokinetic and Clinical Activity of the Combination Compared With Carfilzomib Alone (Part 2) [Phase 1]
A Phase 1 study evaluating afuresertib in combination with carfilzomib for relapsed/refractory multiple myeloma, including dose determinatio…
-
CLINICAL_TRIALS research · 2016-04-29Clinical Trial Update: Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant [NA]
Clinical trial investigating fractionated stem cell infusions in multiple myeloma patients undergoing autologous stem cell transplant; the s…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies [Phase 2]
Phase 2 clinical trial investigating thiotepa-based conditioning for allogeneic stem-cell transplantation in lymphoid malignancies, includin…
-
CLINICAL_TRIALS research · 2016-04-20Clinical Trial Update: CyBorD vs. PAD in the Treatment of Newly Diagnosed Multiple Myeloma [Phase 3]
A Phase 3 clinical trial update comparing CyBorD with PAD for newly diagnosed multiple myeloma. The regimens consist of cyclophosphamide, bo…